Key result
Mutations in the KCNQ1 gene closely neighboring the A341 residue are associated with an intermediate clinical severity in long QT syndrome type 1 compared to A341V and mutations outside this region.
Why the study?
Does knowledge of the mutation location in hereditary long QT syndrome aid risk stratification?
Does knowledge of the mutation location in hereditary long QT syndrome aid risk stratification?
Answers are grounded in this paper and cite their sources.
Identifying specific mutation locations in the KCNQ1 S6 region, particularly around A341, aids in risk stratification for patients with long QT syndrome type 1 by predicting worse clinical outcomes.
This editorial refers to ‘Mutation location and I Ks regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region’, by P.J. Schwartz et al., doi:10.1093/eurheartj/ehab582. Long QT syndrome promotes early afterdepolarizations (EADs) with L-type calcium channel reactivation and acts as a substrate for torsade de pointes (blue box). LQT1 is caused by mutations in the KCNQ1 potassium channel which, in complex with KCNE1, underlies the cardiac IKs current (upper panel left). Autosomal dominant disease can occur because of loss of function (upper panel right) or a dominant negative mechanism (lower panel right). Aberrant regulation mediated by protein kinase C or PIP2 may also be a cause of disease, though this is less well defined (bottom panel right). AC, adenylate cyclase; AKAP, a kinase-anchoring protein. The structural images of the effect of PIP2 on KCNQ1 are from Sun and MacKinnon.15 The hereditary long QT syndromes (LQTSs) (Graphical Abstract) are an important cause of sudden cardiac death in the young.1 , 2 Individuals have a prolonged resting rate-corrected QT interval (QTc) on the ECG and are liable to torsade de pointes which can degenerate into ventricular fibrillation. The afflicted have structurally normal hearts, and a series of pivotal genetic studies have revealed causative mutations in ion channel subunits and their auxiliary proteins underlying the human ventricular cardiac action potential. The three most common syndromes involve the genes KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3) which are responsible for the slow and rapid delayed rectifier potassium currents (IKs and IKr, respectively) and the cardiac sodium current.1 , 2 An important question is whether knowledge of the location and functional effects of the channel mutation is useful for predicting the clinical course of the patients. In this issue of the European Heart Journal, Schwartz and colleagues define a new high risk subgroup with KCNQ1 mutations in LQT1 (Graphical Abstract).3 Previous studies from this group had shown that a mutation A341V in the sixth transmembrane segment of KCNQ1 had a particularly malignant clinical course.4 In this new study, they show that mutations closely neighbouring this residue had an intermediate severity to that of A341V and mutations outside this region, specifically as evidenced by an intermediate time to first cardiac event before the age of 40 and the QTc.3 It is a tribute to the investigators that they assembled such large clinical cohorts where these questions could be addressed with sufficient statistical power. However, the findings also raise interesting questions about the molecular pathophysiology of why this should occur. KCNQ1 is a member of the Kv7 family of voltage-gated potassium channels and a subunit has six transmembrane domains with an intracellular N- and C-terminus.5 The channel forms as a homotetramer and, in cardiomyocytes, complexes with the auxiliary subunit KCNE1 to underpin the IKs (Graphical Abstract). The interaction with KCNE1 is key to generating the characteristic biophysical properties of the IKs including the slow activation and lack of inactivation.5 The IKs is largely responsible for shortening of the action potential duration and QT interval with increased heart rate during exercise. The increased heart rate per se recruits more IKs as it fails to fully deactivate between beats (though this may require some beta-adrenergic stimulation) and the current also increases because of protein kinase A- (PKA) mediated phosphorylation of KCNQ1 due to beta-adrenoreceptor activation (Graphical Abstract).6 The LQTS was first recognized in an autosomal recessive form as part of a syndrome that included deafness.7 The patients often suffered severe cardiac disease at a young age. The mutations underlying this are often nonsense or frameshifts resulting in complete loss of function due to nonsense-mediated RNA decay or the failure of channel assembly (Graphical Abstract).8 , 9 Heterozygotic carriers in these pedigrees are often well without cardiac pathology. Highly penetrant severe cardiac disease also occurs with compound heterozygotic mutations in KCNQ1 without deafness.10 In general, these mutations are associated with complete or severe loss of KCNQ1 channel protein and function in heterologous expression systems.1 However the autosomal dominant form of the disease is much more common and here variable penetrance is a well-recognized feature of the disease.11 This, together with the variability seen in an individual’s response to drugs that prolong the QT interval, has led to the concept of ‘repolarization reserve’ reflecting the capacity of the ventricle to tolerate reduction in repolarizing currents without adverse effects. In the first major study to correlate mutation location with disease, Moss et al. found that mutations in the transmembrane domains had a more pronounced effect on event occurrence than those in the C-terminus.12 The tetrameric nature of potassium channels opens up the possibility of another genetic mechanism, namely the dominant negative effect (Graphical Abstract). Thus at its most severe, a single mutant subunit in the tetramer might potentially inactivate the function of the other three normal subunits and, if expression from both alleles is equivalent, this could reduce currents by ∼90% (Graphical Abstract). In addition, these investigators found that mutations with a strong dominant negative effect were also associated with a worse outcome.12 The mutant KCNQ1 channels, generally missense mutations, may not conduct or gate properly at the sarcolemma but might also fail to traffic to the plasma membrane and be retained in the endoplasmic reticulum.1 The explanation for the pronounced pathogenicity of the A341V was initially unclear as it had a small dominant negative effect. However, using conditions that mimic the regulation of the channel by beta-adrenoreceptors and PKA (Graphical Abstract), they found that even in the heterozygote state, channel activation was severely abrogated.3 Incidentally, the extensive family pedigrees of A341V allowed investigation of potential modifier genes and an explanation for reduced repolarization reserve. Thus evidence was found for the involvement of the gene encoding nitric oxide synthase adaptor protein 1 (NOS1AP) in shaping outcomes, nicely dovetailing with the involvement of NOS1AP in determining population-level variations in QTc from genome-wide association studies.1 , 13 , 14 The question then is what is the explanation for the intermediate behaviour of the mutants adjacent to A341? Assays for activation by PKA in the heterozygous state revealed that this remained intact, though there was a disparity in the magnitude, and any dominant negative effect was variable in severity. Technically these experiments are quite challenging as up to four individual plasmids need to be transiently transfected into the cells and it is difficult to titrate the exact proportions in each individual cell. Thus direct experimental validation of the mechanism awaits further experimentation. However, a number of high resolution structures of KCNQ1 have been published and these may give some insight into potential mechanisms.15 The key segment in S6 is 338SFFALPAGILGS349. The authors actually define adjacent to A341 as between amino acids 328 and 348, but they have not ascertained mutations at some residues.3 The structures reveal the differences that occur between an open and a closed KCNQ1 channel by cleverly comparing the structures in complex with KCNE3 with and without phosphatidylinositol-(4,5)-bisphosphate (PIP2).15 KCNE3 renders KCNQ1 open at essentially all voltages in the presence of PIP2, and the complex behaves as a leak conductance.5 , 15 The channel complex is closed in the absence of PIP2. A comparison of the open and closed structures shows that an inner gate around S349 expands from 1 Å to 3.5 Å due to bending within the PAG motif (amino acids 343–345) (Graphical Abstract). In addition, an RQKH motif (amino acids 360–363) transition from a loop to a helix, rendering the S6 helix and the first helix in the C-terminus, known as the HA helix, a single contiguous helical structure (Graphical Abstract). Thus the A341 adjacent residues are involved in transition from a closed to an open channel mediated by PIP2. PIP2 is an essential cofactor for the function of a number of ion channels. It can also act as a second messenger in signalling. Indeed one of the best characterized examples of this is the M current which is constituted of other members of the Kv7 family, namely KCNQ2, KCNQ3, and KCNQ5 in heteromultimers. Inhibition of the M current occurs after PIP2 reduction caused by activation of muscarinic receptors coupled to the Gq\11 family of G proteins.5 PIP2 is a substrate for phospholipase C, generating diacylglcerol and inositol triphosphate, but can be depleted in the process. In general, there has been much less work on whether IKs and KCNQ1 can be regulated in a similar fashion. However, the location of the hotspot residues in S6 which acts a key transduction motif for PIP2-mediated opening raises the issue of whether these mutant complexes might be abnormally regulated by PIP2 and be hypofunctional as a result. In conclusion, the study by Schwartz and colleagues identifies a series of mutations at and around A341 that lead to worse outcomes than those in other regions of the channel. These mutant complexes do not show impaired PKA regulation, and the exact molecular mechanism will need further experimentation. In addition, as polygenic risk scores are developed for a number of cardiovascular traits including ventricular arrhythmia, it will be interesting if these can also contribute to additional risk stratification in LQTS and other hereditary arrhythmic syndromes. The work in the author’s laboratory is supported by the British Heart Foundation, Medical Research Council, National Institutes of Health Research Cardiovascular Biomedical Centre at Barts and The London, National Institutes of Health, and Barts Charity. Conflict of interest: none declared. The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
No takes yet. Share an insight, caveat, or question.
Andrew Tinker (2021) conducted an editorial in Hereditary long QT syndrome (LQT1). KCNQ1 mutations adjacent to A341 vs. Mutations outside this region or A341V was evaluated. Mutations in the KCNQ1 gene closely neighboring the A341 residue are associated with an intermediate clinical severity in long QT syndrome type 1 compared to A341V and mutations outside this region.
Synapse has enriched 10 related papers. Consider them for comparative context: